If you are an American founder, investor, or US parent group running a UK trading subsidiary, corporation tax for US-owned UK companies 2026 covers the full UK CT framework alongside the US-side reporting through Form 5471, GILTI inclusions under IRC Section 951A, and the Section 962 election that typically eliminates the US tax overlay on […]
If you are an American founder, investor, or US parent group running a UK trading subsidiary, corporation tax for US-owned UK companies 2026 covers the full UK CT framework alongside the US-side reporting through Form 5471, GILTI inclusions under IRC Section 951A, and the Section 962 election that typically eliminates the US tax overlay on UK trading profit. The UK Corporation Tax main rate sits at 25 percent above £250,000 of profit, with the 19 percent small profits rate below £50,000 and marginal relief in between. However, a US parent business with several UK subsidiaries often pays at the main rate starting with the first pound due to the linked firm division under FA 2022.The single point worth holding onto: the merged R&D scheme from 1 April 2024, the Patent Box at 10 percent effective rate on qualifying IP profits, and Section 962 election coordination together usually deliver an effective combined US-UK tax rate below 22 percent on trading profit — but only if the structure is built to take advantage of all three. Read on for the full breakdown.
The story starts when a US parent group decides to expand into the UK. Sometimes through an acquisition of an existing UK target, sometimes through a greenfield UK subsidiary, sometimes through the natural growth of UK sales from a US-only base. The UK tax framework that meets them is more complex than the US headline rate of 21 percent suggests — multiple corporation tax bands, an associated company rule that can wipe out the lower band entirely, transfer pricing rules biting from a much lower threshold than many US groups expect, and a Pillar Two GloBE regime that adds a 15 percent floor for larger groups.
This guide walks through how corporation tax for US-owned UK companies in 2026 works across the full UK and US frameworks, what the 2025 Budget changes mean for US-owned structures, and the specific optimization moves that take effective combined rates from over 30 percent down to the low 20s. For broader cross-border guidance, see our US-UK cross-border tax advisory service.
UK Corporation Tax under the Corporation Tax Act 2009 and the Corporation Tax Act 2010 applies to the worldwide profits of UK-resident companies and to the UK-source trading profits of non-UK-resident companies operating through a UK permanent establishment. The main rate is 25 percent for accounting periods starting on or after 1 April 2023, applied to profits above £250,000 per accounting period. The small profits rate of 19 percent applies to profits below £50,000. Marginal relief applies between £50,000 and £250,000, producing an effective marginal rate of 26.5 percent on the slice between the two thresholds.
The thresholds are divided by the number of associated companies under FA 2022 Section 6 (which inserted CTA 2010 Section 18D-18H). A US parent group with three UK trading subsidiaries divides the £50,000 and £250,000 thresholds by three, leaving each UK subsidiary with a small profits rate threshold of £16,667 and a main rate threshold of £83,333. Most US-owned UK companies in any meaningful group pay at the 25 percent main rate on the first pound of profit because the dividend thresholds bite quickly.
For corporation tax US-owned UK companies 2026, the framework also includes the merged R&D scheme from 1 April 2024 under Finance Act 2024 (20 percent above-the-line tax credit, 27 percent enhanced credit for R&D-intensive SMEs under CTA 2009 Part 13), the Patent Box at 10 percent effective rate on qualifying IP profits under CTA 2010 Part 8A, the Corporate Interest Restriction under TIOPA 2010 Part 10 capping deductible interest at 30 percent of UK tax-EBITDA with a £2 million de minimis, and Pillar Two GloBE rules for groups with consolidated revenue above €750 million. The HMRC Corporation Tax rates reference sits at https://www.gov.uk/government/publications/rates-and-allowances-corporation-tax.
The US side adds the Controlled Foreign Corporation framework under IRC Sections 951-965, GILTI inclusions under Section 951A on the UK subsidiary’s tested income, Form 5471 reporting per US shareholder per CFC per year, and the Section 962 election under IRC Section 962 that lets individual US shareholders access the 21 percent corporate rate plus foreign tax credit relief on GILTI inclusions.
Three developments make 2026 a particularly active year for US-owned UK structures.
First, the FA 2025 long-term residence framework, which replaced the UK domicile regime, affects how UK-resident American founders and shareholders sit in relation to their UK companies. Founders who reach the 10-of-20-year long-term residence trigger face UK Inheritance Tax exposure on their worldwide estate, including their UK company shares. Planning moves (UK Discretionary Trust formation, lifetime gifting, share class restructuring) need to integrate with the Corporation Tax framework.
Second, the US 2026 lifetime estate and gift tax exemption sunset on 1 January 2026 (reducing from $13.99 million per person to approximately $7 million absent Congressional action) makes lifetime gifting of UK company shares before the deadline a coordinated planning move. The Section 962 election positioning and the GILTI inclusion history affect the US-side basis on those gifts.
Third, the OECD Pillar Two GloBE rules came into UK Corporation Tax through FA 2023 Part 3, applying to multinational groups with consolidated revenue above €750 million across at least two of the four prior accounting periods. The Pillar Two top-up tax under the Multinational Top-Up Tax (MTT) and the Domestic Top-Up Tax (DTT) frameworks adds a 15 percent effective tax rate floor on UK profits where the group’s effective tax rate falls below 15 percent. Many US-owned groups previously below the threshold are now within scope. For deeper context, see our US-UK Treaty advisory service.
The merged R&D scheme replaced the prior two-track regime (SME credit at 130 percent enhanced deduction plus 14.5 percent payable credit for loss-makers, and Research and Development Expenditure Credit at 20 percent for larger companies) for accounting periods starting on or after 1 April 2024. The merged scheme provides a 20 percent above-the-line tax credit on qualifying R&D expenditure under CTA 2009 Part 13.
US-owned UK companies undertaking software development, biotech research, hardware engineering, or any qualifying R&D activity typically generate substantial credits under the merged scheme. The credit is taxable income for Corporation Tax purposes (gross 20 percent reduces to roughly 15 percent net after CT), but provides a genuine cash benefit either as a reduction in CT liability or as a payable cash credit for companies in losses.
The R&D-intensive SME enhanced rate of 27 percent applies to companies meeting the R&D intensity threshold (R&D expenditure at 30 percent or more of total expenditure for accounting periods starting on or after 1 April 2024, reduced from the original 40 percent threshold). The enhanced rate is materially more valuable than the standard 20 percent rate and applies to early-stage US-owned UK companies investing heavily in R&D before achieving revenue scale.
The Patent Box under CTA 2010 Part 8A applies a 10 percent effective Corporation Tax rate to profits derived from qualifying patents and similar IP rights. For a US-owned UK company holding qualifying UK or European patents, software-related IP, or other patentable innovation, the Patent Box election under CTA 2010 Section 357A reduces the effective CT rate on the relevant IP profit from 25 percent to 10 percent.
The Patent Box mechanism uses a streaming approach to identify qualifying IP profits and a Nexus calculation under the OECD modified Nexus approach (introduced by FA 2016 to align with BEPS Action 5), which requires that the qualifying IP be developed through substantial UK R&D activity. The Patent Box claim is made on the Corporation Tax return for the relevant accounting period and runs alongside the merged R&D scheme claim — both can apply to the same IP-rich UK company.
Full expensing under CTA 2009 Section 7 (introduced by FA 2023) provides 100 percent first-year capital allowance on qualifying main rate plant and machinery purchases by companies. The 50 percent first-year allowance applies to special rate pool items. Full expensing is permanent from 1 April 2026 onwards under the FA 2024 confirmation, removing the prior planned expiry.
For a US-owned UK company investing in qualifying plant and machinery — UK office fit-out, manufacturing equipment, IT hardware, commercial vehicles — the full expensing regime delivers an immediate 25 percent tax saving on every qualifying pound of investment. The structures and buildings allowance (SBA) at 3 percent per year applies to qualifying non-residential structures and buildings, less generous than full expensing but still useful for property-heavy US-owned UK operations. The HMRC capital allowances reference sits at https://www.gov.uk/capital-allowances.
Step 1 — Identify the UK Corporation Tax band and any associated company divisions. Count all UK-resident associated companies under the FA 2022 framework — typically every UK subsidiary in the US parent group. Divide the £50,000 small profits threshold and £250,000 main rate threshold by the number of associated companies to determine the effective bands for each UK subsidiary.
Step 2 — Run the R&D claim across the qualifying activity. Identify R&D activity meeting the BEIS guidelines under CIRD81000 onwards. Document qualifying expenditure (staff costs, software, consumables, externally provided workers, subcontractor costs) and prepare the R&D claim submission alongside the Corporation Tax return. The HMRC R&D scheme reference sits at https://www.gov.uk/government/publications/research-and-development-tax-relief-reforms.
Step 3 — Assess Patent Box eligibility on any qualifying IP. Identify qualifying patents, supplementary protection certificates, plant breeders’ rights, and similar IP rights. Run the streaming calculation to identify the qualifying IP profit. Make the Patent Box election under CTA 2010 Section 357A for the accounting period.
Step 4 — Manage transfer pricing on US parent-UK subsidiary transactions. Transfer pricing under TIOPA 2010 Part 4 applies to controlled transactions between the UK subsidiary and the US parent or other group entities. Standard transactions include royalty payments for IP licensed from the US parent, management fees charged by the US parent, intercompany loan interest, and intra-group service charges. Arm’s length pricing under the OECD Transfer Pricing Guidelines is required, and Local File and Master File documentation thresholds apply to larger groups.
Step 5 — Apply the Corporate Interest Restriction. Under TIOPA 2010 Part 10, the Corporate Interest Restriction caps deductible interest at 30 percent of UK tax-EBITDA with a £2 million de minimis. US-owned UK companies that are substantially funded through intercompany loans from the US parent often hit the CIR cap and need to model the disallowed interest.
Step 6 — Coordinate with US-side GILTI and Section 962 positioning. The US parent or individual US shareholders include the UK subsidiary’s tested income on the US side under GILTI. For individual US shareholders, the Section 962 election under IRC Section 962 allows them to access the 21 percent corporate rate and the foreign tax credit on UK Corporation Tax already paid. For corporate US parents, the Section 250 deduction reduces the effective GILTI rate to approximately 10.5 percent, with the foreign tax credit applied to 80 percent of UK CT.
Step 7 — File the Corporation Tax return (CT600) and pay quarterly installments, if applicable. Large companies (taxable profit above £1.5 million in the prior 12 months, divided by associated companies) pay Corporation Tax in four quarterly installments rather than 9 months after period end. Very large companies (with taxable profits above £20 million) pay accelerated quarterly installments. The HMRC CT600 reference sits at https://www.gov.uk/government/publications/corporation-tax-company-tax-return-guide.
A San Francisco-based SaaS group launched its UK operating subsidiary in 2021 to serve growing demand from UK and European customers. The UK subsidiary held 14 UK-based employees by 2025 (engineering, sales, customer success), generated £4.2 million of UK-source revenue in the year to 31 December 2025, and ran a net trading profit of £980,000 before tax. The US parent licensed its core SaaS platform IP to the UK subsidiary under an arm’s length royalty arrangement and charged management fees for US-based executive oversight.
The UK subsidiary sat as one of seven associated companies in the US parent group’s UK and European structure, which reduced the small profits rate threshold to roughly £7,143 (£50,000 divided by seven) and the main rate threshold to roughly £35,714. Every pound of UK profit, therefore, attracted the 25 percent main rate from the first pound, producing a baseline Corporation Tax liability of £245,000 on the £980,000 profit.
We took the engagement in late 2024 ahead of the year-end CT return for the 31 December 2025 accounting period—the diagnostic identified three optimization opportunities. First, the UK subsidiary’s engineering team had spent roughly £680,000 on qualifying R&D to develop UK-specific features and integration capabilities for the SaaS platform. The merged R&D scheme at 20 percent above-the-line credit produced approximately £136,000 of gross R&D credit, reducing to £102,000 net after Corporation Tax. Second, the IP underlying the SaaS platform had two qualifying UK patents covering specific technical implementations. The Patent Box claim on the profit streamed to those patents produced an effective 10 percent rate on roughly £180,000 of qualifying IP profit, reducing CT on that slice from £45,000 to £18,000 — a saving of £27,000. Third, the transfer pricing position on the US parent royalty arrangement was reviewed and benchmarked against comparable arrangements, producing supporting documentation for the OECD arm’s length standard at a royalty rate that satisfied both UK and US tax authorities.
The integrated outcome was a UK Corporation Tax liability of £116,000 on the £980,000 profit — an effective CT rate of 11.8 percent, compared to the headline rate of 25 percent. Adding the US-side GILTI inclusion (with the US parent accessing Section 250 deduction at 10.5 percent effective on the inclusion) and foreign tax credit on UK CT paid, the combined US-UK effective tax rate on the UK trading profit came to approximately 19.8 percent — well below either headline rate in isolation.
The case shows the standard pattern for US-owned UK SaaS subsidiaries. The he%5 percent UKcan lookate looks daunting at first. Still, the merged R&D scheme, Patent Box, full expensing, and Section 962/Section 250 coordination on the US side together typically deliver an effective combined rate in the low 20s — competitive with US-only structures and frequently better.
Ignoring the associated company division of the small profits threshold. US parent groups with multiple UK subsidiaries divide the £50,000 and £250,000 thresholds by the number of associated companies. A group of seven UK subsidiaries reduces the small profits rate threshold to roughly £7,143 per company, meaning every subsidiary pays at the 25 percent main rate from almost the first pound. Many US groups budget on the headline £50,000 small profits threshold and underestimate the actual CT liability.
Missing the merged R&D scheme on routine technical work. The merged R&D scheme, with a 20 percent above-the-line credit, applies to a much broader range of activities than many US-owned UK companies realize. Software development, technical engineering, biotech research, hardware design, and even some advanced analytics work can qualify. The CIRD81000 guidelines apply the OECD definition of R&D, and the qualifying activities must seek to advance scientific or technological knowledge rather than merely be commercially novel.
Setting royalty and management fee transfer pricing without documentation. Under TIOPA 2010 Part 4, transfer pricing requires arm’s-length pricing for controlled transactions between the UK subsidiary and the US parent. Companies that set royalty rates at convenient round numbers (5 percent, 10 percent, 20 percent of revenue) without benchmarking expose themselves to HMRC transfer pricing adjustments and potential double taxation. Proper benchmarking studies and Local File documentation are standard for transactions above the documentation thresholds.
Missing Pillar Two GloBE applicability for groups above €750 million. Multinational groups with consolidated revenue above €750 million across at least two of the four prior accounting periods fall within Pillar Two scope under the OECD framework as implemented by FA 2023 Part 3. The Multinational Top-Up Tax (MTT) and Domestic Top-Up Tax (DTT) frameworks impose a 15 percent effective rate floor on UK profits. Many US-owned groups newly reaching the threshold underestimate the compliance burden and timing.
Ignoring the Corporate Interest Restriction on intercompany loans. US parent groups often fund UK subsidiaries through significant intercompany loan arrangements. The Corporate Interest Restriction under TIOPA 2010 Part 10 caps deductible interest at 30 percent of UK tax-EBITDA, with a £2 million de minimis threshold. Disallowed interest carries forward, but the cash flow impact in the year of disallowance is material. The HMRC Corporate Interest Restriction reference sits at https://www.gov.uk/hmrc-internal-manuals/corporate-finance-manual/cfm95000.
Failing to coordinate UK CT positioning with US GILTI and Section 962 elections. US individual shareholders of UK subsidiaries face GILTI inclusions under IRC Section 951A on the UK tested income each year. Without the Section 962 election, GILTI is subject to individual marginal rates up to 37 percent federal plus state tax — even if the UK has already taxed the same profit at 25 percent. The Section 962 election typically eliminates the US individual tax overlay by absorbing foreign tax credits.
Jungle Tax holds CIOT (Chartered Institute of Taxation) credentials and ACCA membership with team members holding IRS Enrolled Agent status for US-side representation. Our team handles UK Corporation Tax return preparation (CT600), R&D claim submissions under the merged scheme, Patent Box elections under CTA 2010 Section 357A, transfer pricing benchmarking and Local File documentation under TIOPA 2010 Part 4, Corporate Interest Restriction modelling under TIOPA 2010 Part 10, and the integrated coordination with US Form 5471 reporting, GILTI inclusions, and Section 962 elections.
A typical engagement for a US-owned UK company running across the 2026 CT cycle covers three streams. First, the structural diagnostic — associated company division of the small profits threshold, transfer pricing position on US parent transactions, Corporate Interest Restriction modeling on intercompany loans, Pillar Two GloBE applicability check for larger groups, and merged R&D scheme and Patent Box eligibility review. Second, the return preparation — CT600 with all supporting schedules, R&D claim with technical narrative and qualifying expenditure documentation, Patent Box streaming calculation, transfer pricing supporting documentation, and the integrated cross-border modeling against US-side GILTI and Section 962 positioning. Third, ongoing compliance and quarterly review — quarterly Corporation Tax installments, where applicable; transfer pricing documentation refresh; year-end planning around capital allowances and full expensing; and coordination with the US parent’s quarterly and annual reporting cycles.
For broader cross-border guidance, see our US-UK cross-border tax advisory service and our transfer pricing and international tax service. Contact info@jungletax.co.uk to discuss your structure.
Three points to take away. First, corporation tax on US-owned UK companies 2026 rewards structural awareness — the associated company division of the small profits threshold under FA 2022 means most US-owned UK subsidiaries pay at the 25 percent main rate from the first pound rather than at the headline small profits rate of 19 percent. Budgeting based on the headline 19 percent threshold typically understates the actual liability by significant amounts. Second, the optimization levers (merged R&D scheme at 20 percent above-the-line credit, Patent Box at 10 percent effective rate on qualifying IP profit, full expensing on plant and machinery, transfer pricing benchmarking, Corporate Interest Restriction modeling) together typically reduce the effective UK CT rate from the 25 percent headline into the 12-18 percent range for IP-rich US-owned UK subsidiaries. Third, US-side coordination through GILTI, Section 250 deductions for corporate US parents, and Section 962 elections for individual US shareholders typically delivers an effective combined US-UK rate in the low 20s — competitive with US-only structures and often better. Speak to a Jungle Tax adviser today — contact us at info@jungletax.co.uk or visit https://www.jungletax.co.uk/.
UK Corporation Tax sits at 25 percent main rate on profits above £250,000, 19 percent small profits rate on profits below £50,000, and marginal relief between the two bands producing an effective marginal rate of 26.5 percent on the £50,000-£250,000 slice. The £50,000 and £250,000 thresholds are divided by the number of associated companies under FA 2022 Section 6, meaning most US parent groups with multiple UK subsidiaries pay at the 25 percent main rate on the first pound of profit per subsidiary. The HMRC Corporation Tax rates reference sits at https://www.gov.uk/government/publications/rates-and-allowances-corporation-tax.
The merged R&D scheme from 1 April 2024 under CTA 2009 Part 13 provides a 20 percent above-the-line tax credit on qualifying R&D expenditure for accounting periods starting on or after that date. The R&D-intensive SME enhanced rate of 27 percent applies to companies meeting the 30 percent R&D intensity threshold. US-owned UK companies undertaking software development, technical engineering, biotech research, or other qualifying R&D activities claim the credit on their CT return, alongside qualifying expenditure documentation, under the BEIS guidelines at CIRD81000.
Yes. The Patent Box under CTA 2010 Part 8A applies a 10 percent effective Corporation Tax rate to profits derived from qualifying patents, supplementary protection certificates, and similar IP rights. The election is made under CTA 2010 Section 357A on the CT return for the relevant accounting period. The streaming calculation identifies qualifying IP, and the OECD modified Nexus approach requires that the qualifying IP have been developed through substantial UK R&D activity. US-owned UK companies holding UK or European patents covering their commercial activity typically benefit substantially from the Patent Box.
GILTI under IRC Section 951A includes the UK subsidiary’s tested income on the US shareholder’s Form 1040 each year, regardless of UK distributions. Without the Section 962 election, GILTI is subject to the individual marginal rate, up to 37 percent federal plus state tax. The Section 962 election under IRC Section 962 allows individual US shareholders to access the 21 percent corporate rate and the foreign tax credit on UK Corporation Tax already paid by the UK subsidiary, typically eliminating the US individual tax overlay. The IRS GILTI reference is available at https://www.irs.gov/businesses/corporations/global-intangible-low-taxed-income-gilti.
Under FA 2022 Section 6 (inserting CTA 2010 Section 18D-18H), the £50,000 small profits threshold and £250,000 main rate threshold are divided by the number of associated companies (broadly, companies under common control with the relevant company). A US parent group with seven UK subsidiaries divides both thresholds by seven, leaving each subsidiary with a £7,143 small profits threshold and a £35,714 main rate threshold. Most US-owned UK companies in any meaningful group pay at the 25 percent main rate from the first pound because the divided thresholds bite quickly.
Transfer pricing under TIOPA 2010 Part 4 applies to controlled transactions between the UK subsidiary and the US parent or other group entities, requiring arm’s length pricing under the OECD Transfer Pricing Guidelines. Standard transactions include royalty payments for IP licensed from the US parent, management fees charged by the US parent, intercompany loan interest, and intra-group service charges. Local File and Master File documentation thresholds apply to larger groups (broadly groups with consolidated revenue above €750 million annually). HMRC transfer pricing guidance availableis available at https://www.gov.uk/hmrc-internal-manuals/international-manual/intm410000.
Pillar Two GloBE rules under FA 2023 Part 3 apply to multinational groups with consolidated revenue above €750 million across at least two of the four prior accounting periods. The Multinational Top-Up Tax (MTT) and Domestic Top-Up Tax (DTT) frameworks impose a 15 percent effective tax rate floor on UK profits where the group’s effective tax rate falls below 15 percent. Smaller US-owned UK groups with consolidated revenue below €750 million fall outside Pillar Two scope and operate under the standard Corporation Tax framework only.
